EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interferon-λ inhibits immunopathology and boosts T cell–mediated immunity in a mouse model of mucosal viral infection

Emily Feng, Alexa Mansour, Elizabeth Balint, Alyssa Mark, Sofia Tramonte, Jonathan K Monteiro, Madison Read, Marie Joe Adaimy, Zhou Xing, Matthias Mack, Sergei V Kotenko, Deanna M Santer und 1 weitere

Journal of Clinical Investigation · 2026

DOI: 10.1172/jci198863 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Emily Feng und 12 weiteren Autor:innen. Beteiligte Einrichtung: McMaster Immunology Research Centre, Department of Medicine and. Hauptthemen laut MEDLINE: Herpesvirus 2, Human, Herpes Genitalis, Immunity, Cellular, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferon lambda (IFN-λ) has emerged as a critical inducer of immune regulation in addition to its mucosal antiviral properties. However, the cellular and molecular mechanisms that govern its dual role during viral infections remain unclear. Here, we discovered that mucosal delivery of IFN-λ abrogates the herpes simplex virus type 2–induced (HSV-2-induced) vaginal tissue pathology observed in the absence of type I IFN signaling, through drastically inhibiting IL-6 production. At the same time, we demonstrated that IFN-λ rescued local production of CD4 + T cell–dependent IFN-γ, which is essential for protection against the development of toxic megacolon following genital HSV-2 infection. Mechanistically, we found that IFN-λ enhances the differentiation of CCR2 + Ly6C hi cells into monocyte-derived antigen-presenting cells, thereby boosting T cell responses. In vivo depletion of CCR2 + cells abrogated this phenomenon. Together, these findings suggest that IFN-λ orchestrates a potent antiviral response, inhibiting hyperinflammatory responses while selectively augmenting effector T cell function. This study positions IFN-λ as a promising therapeutic candidate for enhancing local antiviral immunity and offers new insights into the regulation of immune responses in the context of mucosal viral infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 2, HumanHerpes GenitalisImmunity, CellularCD4-Positive T-LymphocytesImmunity, MucosalAnimalsFemaleMiceInterferon-gammaDisease Models, AnimalInterferon LambdaMice, Inbred C57BLMice, KnockoutInterleukin-6Receptors, CCR2InterferonsVaginaInterleukins

Stichwörter der Autor:innen

Adaptive immunityCytokinesImmunologyInfectious diseaseInflammationInnate immunity

Substanzen

Interferon-gammaInterferon LambdaInterleukin-6interferon-lambda protein, mouseReceptors, CCR2Ccr2 protein, mouseinterleukin-6, mouseInterferonsInterleukinsIFNG protein, mouse

Autor:innen und Institutionen

  • McMaster Immunology Research Centre, Department of Medicine and.
  • Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
  • University Hospital Regensburg, Department of Nephrology, Regensburg, Germany.
  • Department of Microbiology, Biochemistry, and Molecular Genetics, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Centre for Discovery in Cancer Research, McMaster University, Hamilton, Ontario, Canada.

Förderung

  • Canadian Institutes of Health Research

Zitieren

APA

Feng, E., Mansour, A., Balint, E., Mark, A., Tramonte, S., Monteiro, J. K., Read, M., Adaimy, M. J., Xing, Z., Mack, M., Kotenko, S. V., Santer, D. M., & Ashkar, A. A. (2026). Interferon-λ inhibits immunopathology and boosts T cell–mediated immunity in a mouse model of mucosal viral infection. Journal of Clinical Investigation. https://doi.org/10.1172/jci198863

Vancouver

Feng E, Mansour A, Balint E, Mark A, Tramonte S, Monteiro JK, et al. Interferon-λ inhibits immunopathology and boosts T cell–mediated immunity in a mouse model of mucosal viral infection. Journal of Clinical Investigation. 2026. doi:10.1172/jci198863

BibTeX
@article{Feng2026,
  author = {Feng, Emily and Mansour, Alexa and Balint, Elizabeth and Mark, Alyssa and Tramonte, Sofia and Monteiro, Jonathan K and Read, Madison and Adaimy, Marie Joe and Xing, Zhou and Mack, Matthias and Kotenko, Sergei V and Santer, Deanna M and Ashkar, Ali A},
  title = {Interferon-λ inhibits immunopathology and boosts T cell–mediated immunity in a mouse model of mucosal viral infection},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci198863}
}
Kostenlos starten →